Filing Details

Accession Number:
0001179110-15-008265
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-05-21 15:34:21
Reporting Period:
2015-05-21
Filing Date:
2015-05-21
Accepted Time:
2015-05-21 15:34:21
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1423824 Alder Biopharmaceuticals Inc ALDR Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1033501 M Stephen Dow C/O Sevin Rosen Funds
13355 Noel Road, Suite 1350
Dallas TX 75240
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2015-05-21 20,000 $65.69 314,203 No 4 S Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect See Footnote
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 19,869 Direct
Footnotes
  1. This sale was made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person.
  2. The shares sold on this date were sold in multiple transactions. This price is the weighted average sales price per share of all shares sold on this date. The actual sale prices per share range from $65.35 - $66.09.
  3. Total common shares of 314,203 represents 256,703 common shares held by the Dow Family Trust ("Dow Trust"), 50,000 shares held by Dow Investments II L.P. ("Dow Investments") and 7,500 shares held by Dow Investments L.P. ("Dow L.P."). The Dow Trust is the General Partner of Dow Investments. Steve Dow ("Dow") is a trustee and beneficiary of the Dow Trust. Dow is a general partner of Dow L.P. and is deemed to have sole dispositive power over the shares with no pecuniary interest.